跳至主要内容
临床试验/JPRN-jRCTs031200171
JPRN-jRCTs031200171招募中2 期

Efficacy of triple therapy with vonoprazan, clarithromycin, and metronidazole as Helicobacter pylori eradication therapy for paritents allergic to panicillin: single arm interventional study

Sue Soichiro0 个研究点目标入组 30 人开始时间: 2020年10月26日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients infected with Helicobacter pylori. Patients allergic to penicillin. Patients who give a written informed consent.

排除标准

  • Past history of Helicobacter pylori eradication therapy. Pregnancy or lactation. Past history of allergy for the drugs used in this therapy (vonoprazan, clarithromycin, or metronidazole).
  • Patients using atazanavir, rilpivirine, pimozide, ergotamine, suvorexant, lomitapide mesylate, tadalafil, ticagrelor, ibrutinib, asuna previr, ivavradine, venetoclax, lurasidone hydrochloride, anamorelin hydrochloride, finerenone, or isavuconazonium sulfate. Patients using colchicine with liver dysfunction or renal dysfunction. Patients with cerebrospinal disease. Severe liver dysfunction, severe renal dysfunction, severe heart dysfunction. Patients who are disqualified for the study by physicians.

研究者

发起方
Sue Soichiro

相似试验